ATE295418T1 - Ige-abhängiger histamin-freisetzender faktor rezeptor, bindende peptide, dafür kodierende nukleinsäuren und ihre verwendungen - Google Patents

Ige-abhängiger histamin-freisetzender faktor rezeptor, bindende peptide, dafür kodierende nukleinsäuren und ihre verwendungen

Info

Publication number
ATE295418T1
ATE295418T1 AT01113424T AT01113424T ATE295418T1 AT E295418 T1 ATE295418 T1 AT E295418T1 AT 01113424 T AT01113424 T AT 01113424T AT 01113424 T AT01113424 T AT 01113424T AT E295418 T1 ATE295418 T1 AT E295418T1
Authority
AT
Austria
Prior art keywords
ige
nucleic acids
binding peptides
releasing factor
factor receptor
Prior art date
Application number
AT01113424T
Other languages
English (en)
Inventor
Kyunglim Lee
Junho Chung
Wha Jung Kim
Daehyun-Dong
Miyoung Kim
Jaehoon Jung
Original Assignee
Kyunglim Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyunglim Lee filed Critical Kyunglim Lee
Application granted granted Critical
Publication of ATE295418T1 publication Critical patent/ATE295418T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
AT01113424T 2000-06-01 2001-06-01 Ige-abhängiger histamin-freisetzender faktor rezeptor, bindende peptide, dafür kodierende nukleinsäuren und ihre verwendungen ATE295418T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20000030130 2000-06-01

Publications (1)

Publication Number Publication Date
ATE295418T1 true ATE295418T1 (de) 2005-05-15

Family

ID=19671028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01113424T ATE295418T1 (de) 2000-06-01 2001-06-01 Ige-abhängiger histamin-freisetzender faktor rezeptor, bindende peptide, dafür kodierende nukleinsäuren und ihre verwendungen

Country Status (7)

Country Link
US (1) US6710165B2 (de)
EP (1) EP1167526B1 (de)
JP (1) JP4295449B2 (de)
KR (1) KR100457350B1 (de)
AT (1) ATE295418T1 (de)
CA (1) CA2347276A1 (de)
DE (1) DE60110683D1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
ES2396368T3 (es) * 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
WO2004113572A1 (en) 2003-06-21 2004-12-29 Ewha University Industry Collaboration Foundation Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition
CA2503838C (en) * 2003-09-08 2014-08-19 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair
WO2006051987A1 (ja) * 2004-11-15 2006-05-18 Periodock, Co., Ltd. エストロゲン依存性疾患、プロスタグランジンｄ（ｐｇｄ）依存性婦人疾患、免疫疾患、癌及び血管新生抑制のための新規医薬品
JP4564926B2 (ja) 2005-01-25 2010-10-20 エワ ユニバーシティ−インダストリー コラボレーション ファウンデーション ヒスタミン分泌能を有する欠失型ＩｇＥ依存的ヒスタミン放出因子、ＨＲＦ結合ペプチドおよびその利用方法
KR100859972B1 (ko) * 2006-02-20 2008-09-25 이화여자대학교 산학협력단 막투과 단백질 도메인 펩타이드
WO2008054792A2 (en) * 2006-10-31 2008-05-08 University Of Toledo Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases
KR101600048B1 (ko) 2014-01-03 2016-03-16 이화여자대학교 산학협력단 화학식 2의 구조를 포함하는 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
KR101576231B1 (ko) * 2014-01-03 2015-12-21 이화여자대학교 산학협력단 화학식 1의 구조를 포함하는 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
KR101600049B1 (ko) 2014-01-03 2016-03-16 이화여자대학교 산학협력단 화학식 3의 구조를 포함하는 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
WO2015102418A2 (ko) * 2014-01-03 2015-07-09 이화여자대학교 산학협력단 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
KR101590952B1 (ko) * 2014-01-03 2016-02-22 이화여자대학교 산학협력단 화학식 5 또는 6의 구조를 포함하는 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
KR101590949B1 (ko) * 2014-01-03 2016-02-22 이화여자대학교 산학협력단 화학식 4의 구조를 포함하는 펩티도미메틱 화합물 및 이를 포함하는 알레르기성 질환 치료용 약학조성물
KR101804291B1 (ko) 2014-06-16 2018-01-10 이화여자대학교 산학협력단 TCTP 이량체형 IgE-의존성 히스타민 방출인자와 이의 수용체간의 결합을 억제하는 TCTP 유래 FL 도메인 및 이의 용도
KR20160148362A (ko) * 2015-06-16 2016-12-26 이화여자대학교 산학협력단 IgE-의존적 히스타민 방출인자(HRF) 결합 펩타이드 및 그들을 코딩하는 핵산의 신규한 용도
KR101803078B1 (ko) 2017-09-21 2017-11-29 이화여자대학교 산학협력단 IgE-의존적 히스타민 방출인자(HRF) 결합 펩타이드 및 그들을 코딩하는 핵산의 신규한 용도
WO2020102108A1 (en) * 2018-11-12 2020-05-22 La Jolla Institute For Allergy And Immunology Compositions and methods of modulating inflammation
WO2021157973A1 (ko) * 2020-02-07 2021-08-12 이화여자대학교 산학협력단 페길화된 ige-의존적 히스타민 방출인자(hrf) 결합 펩타이드 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952194A (en) * 1996-08-01 1999-09-14 Heska Corporation Flea nucleic acid sequences and uses thereof
SE9702120D0 (sv) * 1997-06-04 1997-06-04 Karolinska Innovations Ab New selection marker

Also Published As

Publication number Publication date
EP1167526A1 (de) 2002-01-02
US20020095023A1 (en) 2002-07-18
US6710165B2 (en) 2004-03-23
KR100457350B1 (ko) 2004-11-16
KR20010109481A (ko) 2001-12-10
CA2347276A1 (en) 2001-12-01
JP2002330772A (ja) 2002-11-19
EP1167526B1 (de) 2005-05-11
JP4295449B2 (ja) 2009-07-15
DE60110683D1 (de) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE295418T1 (de) Ige-abhängiger histamin-freisetzender faktor rezeptor, bindende peptide, dafür kodierende nukleinsäuren und ihre verwendungen
IL160127A0 (en) Tacis and br3 polypeptides and uses thereof
EP2949658A3 (de) Spezifisch an HGF-Rezeptor (cMet) bindende Peptide und deren Verwendung
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
WO2003093296A3 (en) Kinase anchor protein muteins, peptides thereof, and related methods
EP2360259A3 (de) Promyostatinpeptide und Methoden für deren Verwendung
ZA200308589B (en) Recombinant fusion proteins and the trimers thereof.
ITRM990803A0 (it) Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
DE60122873D1 (de) Therapeutische porenbildende peptide
EP1462455A4 (de) Neue peptide und deren medizinische verwendungen
EP1419175A4 (de) Replikin-peptide und anwendungen
AU2002233457A1 (en) Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
EP1565553A4 (de) Rekombinante katalytische polypeptide und deren verwendungen
DE69816241D1 (de) Aktivierte peptide und konjugate
WO2002064630A3 (en) Il-1 receptor accessory protein
EP1411964A4 (de) Die blutgerinnung modulierende peptide und ihre verwendungszwecke
EP1337543A4 (de) Streptavidin-bindende peptide und deren verwendung
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
AU2002245311A8 (en) Human protein kinase n-like polypeptide and uses thereof
IL159768A0 (en) Polynucleotides encoding glycine transporter polypeptides, their preparation and use
AU4631501A (en) A novel polypeptide, a human protein kinase tak1-27 and the polynucleotide encoding the polypeptide
IL151286A0 (en) A peptide with the sequence gln-tyr-asn-ala-asp, polypeptides containing the same and pharmaceutical compositions containing the same
AU8748101A (en) A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
EP1300416A4 (de) Gedächtnisverstärkende peptide und deren verwendung(16.01.02)
AU2001247283A1 (en) Human transporter proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties